Literature DB >> 14578267

No deterioration in glycemic control in HNF-1alpha maturity-onset diabetes of the young following transfer from long-term insulin to sulphonylureas.

Maggie Shepherd, Ewan R Pearson, Jane Houghton, Gill Salt, Sian Ellard, Andrew T Hattersley.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14578267     DOI： 10.2337/diacare.26.11.3191-a

Source DB:  PubMed          Journal:  Diabetes Care        ISSN： 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  34 in total

1.  To test, or not to test: time for a MODY calculator?

Authors:  P R Njølstad; A Molven
Journal:  Diabetologia       Date:  2012-03-02       Impact factor: 10.122

2.  Diabetic ketoacidosis in the setting of HNF1A-maturity onset diabetes of the young.

Authors:  Aoife M Egan; Aine Cunningham; Bahram Jafar-Mohammadi; Fidelma P Dunne
Journal:  BMJ Case Rep       Date:  2015-04-02

Review 3.  Approach to the patient with atypical diabetes.

Authors:  Devin W Steenkamp; Sara M Alexanian; Elliot Sternthal
Journal:  CMAJ       Date:  2014-01-06       Impact factor: 8.262

4.  The Impact of Biomarker Screening and Cascade Genetic Testing on the Cost-Effectiveness of MODY Genetic Testing.

Authors:  Matthew S GoodSmith; M Reza Skandari; Elbert S Huang; Rochelle N Naylor
Journal:  Diabetes Care       Date:  2019-09-26       Impact factor: 19.112

5.  YIPF5 mutations cause neonatal diabetes and microcephaly: progress for precision medicine and mechanistic understanding.

Authors:  Toni I Pollin; Simeon I Taylor
Journal:  J Clin Invest       Date:  2020-12-01       Impact factor: 14.808

Review 6.  Novel approaches to restore beta cell function in prediabetes and type 2 diabetes.

Authors:  Vishal A Salunkhe; Rajakrishnan Veluthakal; Steven E Kahn; Debbie C Thurmond
Journal:  Diabetologia       Date:  2018-06-08       Impact factor: 10.122

Review 7.  Monogenic syndromes of abnormal glucose homeostasis: clinical review and relevance to the understanding of the pathology of insulin resistance and beta cell failure.

Authors:  J R Porter; T G Barrett
Journal:  J Med Genet       Date:  2005-03-16       Impact factor: 6.318

8.  Approach to the Patient with MODY-Monogenic Diabetes.

Authors:  David T Broome; Kevin M Pantalone; Sangeeta R Kashyap; Louis H Philipson
Journal:  J Clin Endocrinol Metab       Date:  2021-01-01       Impact factor: 5.958

9.  Assessing the phenotypic effects in the general population of rare variants in genes for a dominant Mendelian form of diabetes.

Authors:  Jason Flannick; Nicola L Beer; Alexander G Bick; Vineeta Agarwala; Janne Molnes; Namrata Gupta; Noël P Burtt; Jose C Florez; James B Meigs; Herman Taylor; Valeriya Lyssenko; Henrik Irgens; Ervin Fox; Frank Burslem; Stefan Johansson; M Julia Brosnan; Jeff K Trimmer; Christopher Newton-Cheh; Tiinamaija Tuomi; Anders Molven; James G Wilson; Christopher J O'Donnell; Sekar Kathiresan; Joel N Hirschhorn; Pål R Njølstad; Tim Rolph; J G Seidman; Stacey Gabriel; David R Cox; Christine E Seidman; Leif Groop; David Altshuler
Journal:  Nat Genet       Date:  2013-10-06       Impact factor: 38.330

Review 10.  Pharmacogenetics in diabetes.

Authors:  Ewan R Pearson
Journal:  Curr Diab Rep       Date:  2009-04       Impact factor: 4.810
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.